Track the 바이오에프디엔씨 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 바이오에프디엔씨 has recorded 3 reports. Market capitalisation: €64.7bn. The latest transaction was reported on 8 April 2026 (Other). Among the most active insiders: 모상현. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
BioFDNC 是一家专注于健康和制药领域的公司,在 XKRX 市场上市。该公司致力于为医疗领域开发创新解决方案。